215 cardiovascular disease drugs in the pipeline, report finds

06/13/2013 | Drug Store News · PharmaTimes (U.K.)

A total of 215 drugs for heart disease and stroke are awaiting FDA approval or are in clinical trials, according to a report from the Pharmaceutical Research and Manufacturers of America. The lineup includes 30 for heart failure, 29 for lipid disorders, 19 for stroke and 17 for hypertension.

View Full Article in:

Drug Store News · PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA